BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dos Reis Rosa Franco G, Smid S, Viegas C. Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases. Curr Neuropharmacol 2021;19:449-64. [PMID: 32691712 DOI: 10.2174/1570159X18666200720172624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Galant N, Czarny J, Powierska-Czarny J, Piotrowska-Cyplik A. Development and Validation of the LC-MS/MS Method for Determination of 130 Natural and Synthetic Cannabinoids in Cannabis Oil. Molecules 2022;27. [PMID: 36500694 DOI: 10.3390/molecules27238601] [Reference Citation Analysis]
2 Lah TT, Majc B, Novak M, Sušnik A, Breznik B, Porčnik A, Bošnjak R, Sadikov A, Malavolta M, Halilčević S, Mlakar J, Zomer R. The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling. Cancers (Basel) 2022;14. [PMID: 36497400 DOI: 10.3390/cancers14235918] [Reference Citation Analysis]
3 Laws JS, Smid SD. Evaluating Cannabis Sativa L.’s neuroprotection potential: from bench to bedside. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154485] [Reference Citation Analysis]
4 Eduarda Serafim Crispim M, De Ávila Lins da Cunha Lima J, Braga Santos G, Ribeiro Coutinho de Mendonça Furtado F, Ribeiro Coutinho de Mendonça Furtado B. THE NEUROPROTECTION CAUSED BY PHYTOCANABINOIDS, THEIR EFFECTS AND THEIR APPLICABILITY IN BRAZIL. hs 2022;2:44-63. [DOI: 10.51249/hs.v2i03.796] [Reference Citation Analysis]
5 Feeney W, Moorthy AS, Sisco E. Spectral trends in GC-EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds. Forensic Chem 2020;31. [PMID: 36578315 DOI: 10.1016/j.forc.2022.100459] [Reference Citation Analysis]